Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

Delayed Quote. Delayed  - 05/02 09:15:09 pm
61.37 USD   +0.61%
04/30 ABBVIE : Galapagos and AbbVie expand their cystic fibrosis collabora..
04/30 ABBVIE : Biogen gain CHMP nod for new MS drug Zinbryta
04/29 ABBVIE : agrees to buy Stemcentrx for $5.8bn
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/26/2016 04/27/2016 04/28/2016 04/29/2016 05/02/2016 Date
60.93(c) 60.7(c) 61.2(c) 61(c) 61.37 Last
4 281 696 6 679 223 16 235 445 13 052 698 7 062 431 Volume
-0.07% -0.38% +0.82% -0.33% +0.61% Change
More quotes
Financials ($)
Sales 2016 25 593 M
EBIT 2016 10 831 M
Net income 2016 6 885 M
Debt 2016 24 845 M
Yield 2016 3,72%
Sales 2017 28 116 M
EBIT 2017 12 498 M
Net income 2017 8 591 M
Debt 2017 22 208 M
Yield 2017 4,11%
P/E ratio 2016 14,30
P/E ratio 2017 11,24
EV / Sales 2016 4,83x
EV / Sales 2017 4,30x
Capitalization 98 682 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and... 
Sector
Pharmaceuticals
Calendar
05/04 | 04:40pmPresentation
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
04/30 ABBVIE : Galapagos and AbbVie expand their cystic fibrosis collaboration
04/30 ABBVIE : Biogen gain CHMP nod for new MS drug Zinbryta
04/29 ABBVIE INC. : Entry into a Material Definitive Agreement, Unregistered Sale of E..
04/29 ABBVIE : agrees to buy Stemcentrx for $5.8bn
04/29 ABBVIE : to Present at the Bank of America Merrill Lynch 2016 Global Health Care..
04/29 BIOGEN : and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (D..
04/29DJCancer Drugs Entice Big Buyers -- WSJ
04/29DJAbbott to Acquire St. Jude -- WSJ
More news
Sector news : Specialty & Advanced Pharmaceuticals
09:05pDJActivist Investor to Pressure Stada AG to Explore Potential Sale -- Update
08:55pDJActivist Investor to Pressure Stada AG to Explore Potential Sale Activist Inv..
08:49p ELI LILLY : Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatm..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
News from SeekingAlpha
02:51p Dividend Growth, Safety And Credit Review Of My 76 Dividend Paying Stocks
12:05p IBB Expecting A Rebound Ahead Of ASCO
10:34a Merck making inroads in HCV market with aggressive pricing of Zepatier
09:43a Why I Bought Friday's Dip In Amgen
09:26a BIOTECH FORUM DAILY DIGEST : Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Set..


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions